Literature DB >> 3428377

Egg-grown and tissue-culture-grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology.

R Pyhälä1, L Pyhälä, M Valle, K Aho.   

Abstract

A field strain of influenza A (H3N2) virus isolated in embryonated eggs during the 1984-5 influenza outbreak (A/Finland/13/85E) was compared in an antigenic analysis with virus from the same clinical specimen isolated in MDCK cell cultures (A/Finland/13/85M). The M-virus appeared to be more sensitive to haemagglutination-inhibiting antibodies against heterologous viruses than did the E-virus. The results of propagation and plaque purification experiments support the hypothesis that a single clinical specimen may consist of distinct antigenic variant subpopulations promoted selectively by the host during isolation procedures. Receptor-binding properties are discussed as a possible explanation for this selectivity. A set of 471 paired sera consisting of pre-epidemic and post-epidemic specimens taken from the same subjects in 1984-5 was studied for haemagglutination-inhibiting antibodies to six influenza A (H3N2) virus strains, including the E-virus and the M-virus from A/Finland/13/85. Of the antigens used, the M-virus detected significant antibody increases more frequently than did the E-virus (10.0 v. 5.9%). The superiority of the M-virus may rest primarily in its ability to pick out anamnestic antibody responses. Irrespective of this cross-reactivity, pre-epidemic antibody to the M-virus was fairly well associated with protection. In the set of sera (230 specimens) collected in summer 1985 to represent different age groups, the antibody status against the M-virus was significantly better than the status against the E-virus. The results suggest that, at least in some instances, antibody to MDCK-grown virus is a more accurate indicator of the immune status of a community than antibodies to egg-grown virus variants.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428377      PMCID: PMC2249244          DOI: 10.1017/s0950268800066607

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  17 in total

1.  Analysis of antigenic determinants on internal and external proteins of influenza virus and identification of antigenic subpopulations of virions in recent field isolates using monoclonal antibodies and immunogold labelling.

Authors:  S Patterson; J S Oxford
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Superiority of tissue-culture-grown antigens over egg-grown antigens for serologic diagnosis of influenza B virus infections.

Authors:  J L Lathey; L P Van Voris; R B Belshe
Journal:  J Med Virol       Date:  1986-06       Impact factor: 2.327

3.  Antigenic heterogeneity among influenza A(H3N2) field isolates during an outbreak in 1982/83, estimated by methods of numerical taxonomy.

Authors:  W E Beyer; N Masurel
Journal:  J Hyg (Lond)       Date:  1985-02

4.  Serological diagnosis of influenza B virus infection: comparison of an enzyme-linked immunosorbent assay and the hemagglutination inhibition test.

Authors:  R Turner; J L Lathey; L P Van Voris; R B Belshe
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

5.  Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

Authors:  J S Robertson; C W Naeve; R G Webster; J S Bootman; R Newman; G C Schild
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

6.  Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins.

Authors:  S M Carroll; H H Higa; J C Paulson
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

7.  Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.

Authors:  G N Rogers; J C Paulson
Journal:  Virology       Date:  1983-06       Impact factor: 3.616

8.  Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin.

Authors:  C M Deom; A J Caton; I T Schulze
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

9.  Characterization of influenza A-1983 epidemic strains by polyclonal and monoclonal antibodies and detection of two co-circulating antigenic variants.

Authors:  B Styk; F Kostolanský; G Russ; B Tůmová
Journal:  Acta Virol       Date:  1986-05       Impact factor: 1.162

10.  Studies on the adaptation of influenza viruses to MDCK cells.

Authors:  R Rott; M Orlich; H D Klenk; M L Wang; J J Skehel; D C Wiley
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  3 in total

1.  Survey on influenza laboratory diagnostic and surveillance methods in Europe. European Scientific Working Group on Influenza.

Authors:  C Hannoun; B Tumova
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

2.  HA1 domain of influenza A (H3N2) viruses in Finland in 1989-1995: evolution, egg-adaptation and relationship to vaccine strains.

Authors:  R Pyhälä; N Ikonen; M Haanpää; L Kinnunen
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 3.  Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness.

Authors:  Ian G Barr; Ruben O Donis; Jacqueline M Katz; John W McCauley; Takato Odagiri; Heidi Trusheim; Theodore F Tsai; David E Wentworth
Journal:  NPJ Vaccines       Date:  2018-10-09       Impact factor: 7.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.